Jiangsu Province Cancer Hospital

Nanjing, Jiangsu 210008

0 studies enrolling now · 1 studies all time

What they study most

Hepatocellular Carcinoma (HCC)

Studies at this site

• A Study of Tislelizumab Versus Sorafenib in Participants With Unresectable Hepatocellular Carcinoma (HCC) — Completed